{"id":"NCT02937584","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD","officialTitle":"A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Multi-Center Study to Evaluate the Effects of PT001 and PT005 on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-29","primaryCompletion":"2018-05-28","completion":"2018-05-28","firstPosted":"2016-10-18","resultsPosted":"2019-07-24","lastUpdate":"2019-07-24"},"enrollment":23,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD, Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"GP MDI (PT001) 14.4 μg","otherNames":[]},{"type":"DRUG","name":"FF MDI (PT005) 9.6 μg","otherNames":[]}],"arms":[{"label":"GP MDI (PT001) 14.4 μg","type":"EXPERIMENTAL"},{"label":"FF MDI (PT005) 9.6 μg","type":"EXPERIMENTAL"}],"summary":"To assess the effect of treatment with Glycopyronnium (GP) MDI administered twice daily (BID) and Formoterol Fumarate (FF) MDI administered BID on specific image-based airway volumes and resistance in subjects with moderate to severe chronic obstructive pulmonary disease (COPD) following chronic dosing after approximately two weeks treatment.","primaryOutcome":{"measure":"Specific Image-Based Airway Volume (siVaw)","timeFrame":"Baseline, Day 15","effectByArm":[{"arm":"GP MDI","deltaMin":1.11,"sd":null},{"arm":"FF MDI","deltaMin":1.23,"sd":null}],"pValues":[{"comp":"OG000","p":"0.0187"},{"comp":"OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":2,"countries":["Belgium"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4186&filename=PT003019-01_FLUI-2015-140_Protocol_10%20August_Redacted_PDFA.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4186&filename=PT003019-sap-16APR2018-Redacted_PDFA.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":20},"commonTop":["Chronic obstructive pulmonary disease","Influenza"]}}